Coronary Artery Disease Clinical Trials in Torrance, California
5 studies are recruiting for coronary artery disease in Torrance, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Product Surveillance Registry
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…
- Stage
- Not phased
- Ages
- Any age
- Site
- Research site, Torrance, California
- Locations
- 401 in total
- Run by
- Medtronic
-
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.
- Stage
- Phase 2
- Ages
- 18 to 80
- Site
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
- Locations
- 40 in total
- Run by
- Beijing Inno Medicine Co., Ltd.
-
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…
- Stage
- Not phased
- Ages
- Any age
- Site
- Torrance Memorial Medical Center, Torrance, California
- Locations
- 48 in total
- Run by
- Minneapolis Heart Institute Foundation
-
SELUTION 4 De Novo Small Vessel IDE Trial
Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Harbor UCLA, Torrance, California
- Locations
- 70 in total
- Run by
- M.A. Med Alliance S.A.
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…
- Stage
- Not phased
- Ages
- Any age
- Site
- Torrance Memorial Medical Center, Torrance, California
- Locations
- 72 in total
- Run by
- University of British Columbia
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.